ArticlePakistan journal of medical sciences2025
The efficacy of ultrasound-guided radiofrequency ablation for the treatment of papillary thyroid carcinoma.
Article in Pakistan journal of medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Image-Guided Thyroid Ablation versus Surgery for T1N0M0 Papillary Thyroid Carcinoma: A Consensus-Aligned Systematic Review and Meta-Analysis.Balkan medical journal · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study compared the clinical value of ultrasound (US)-guided radiofrequency ablation (RFA) and conventional surgical treatment for papillary thyroid carcinoma (PTMC). Methodology: This retrospective cohort study included clinical data of PTMC patients who underwent routine surgical procedures or US-guided RFA treatment at Xinchang County People's Hospital between April 2023 to July 2024. Perioperative status (surgical duration, intraoperative blood loss, length of hospital stay), changes in the levels of thyroid-related hormones and inflammatory factors and incidence of complications were compared. Results: A total of 125 patients met the criteria for this study. Among them, 60 patients underwent US-guided RFA (RFA group) and 65 underwent routine surgical procedures (surgical group). RFA was associated with better perioperative status than conventional surgery (P<0.05). After the surgery, the levels of thyroid-stimulating hormone (TSH) in both groups increased compared to preoperative levels and were significantly higher in the surgical group compared to the RFA group. The levels of free thyroxine (FT4) and free triiodothyronine (FT3) decreased compared to preoperative levels and were considerably lower in the surgical group than in the RFA group (P<0.05). Postoperative levels of C-reactive protein (CRP), interleukin-6 (IL-6) and tumor necrosis factor - α (TNF - α) in both groups demonstrated a significant increase compared to preoperative level and were markedly higher in the surgical group compared to the RFA group (P<0.05). RFA was associated with a significantly lower incidence of complications compared to conventional surgery (5.00% vs 16.92%, respectively) (P<0.05). Conclusions: US-guided RFA for treating PTMC is more effective than conventional surgical procedures and is associated with better perioperative status and levels of thyroid-related hormones, lower inflammatory response and lower incidence of complications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.